We are live on ! Find out more
FRA

Front Row Advisors Portfolio holdings

AUM $296M
1-Year Est. Return 34.73%
This Fund
S&P 500
This Quarter Est. Return
+11.38%
1 Year Est. Return
+34.73%
3 Year Est. Return
+122.22%
5 Year Est. Return
+164.22%
10 Year Est. Return
–
AUM
$225M
AUM Growth
+$16.4M
Cap. Flow
-$3.11M
Cap. Flow %
-1.38%
Top 10 Hldgs %
37.76%
Holding
984
New
21
Increased
118
Reduced
237
Closed
53

Top Buys

Rank Stock Value
1
QQQ icon
Invesco QQQ Trust
QQQ
+$99K
2
QYLD icon
Global X NASDAQ-100 Covered Call ETF
QYLD
+$81.3K
3
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$71.3K
4
XLK icon
State Street Technology Select Sector SPDR ETF
XLK
+$54.4K
5
ISRG icon
Intuitive Surgical
ISRG
+$53.3K

Top Sells

Rank Stock Value
1
MDT icon
Medtronic
MDT
+$817K
2
NVDA icon
NVIDIA
NVDA
+$217K
3
MRSH
Marsh
MRSH
+$145K
4
FTNT icon
Fortinet
FTNT
+$143K
5
AVGO icon
Broadcom
AVGO
+$143K

Sector Composition

Rank Sector Weight
1 Technology 41.58%
2 Healthcare 11.76%
3 Financials 6.86%
4 Consumer Staples 6.86%
5 Consumer Discretionary 5.43%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
PSK icon
576
State Street SPDR ICE Preferred Securities ETF
PSK
$693M
$7K ﹤0.01%
215
– –
ROCK icon
577
Gibraltar Industries
ROCK
$1.34B
$7K ﹤0.01%
104
– –
SCHR
578
Schwab Intermediately-Term US Treasury ETF
SCHR
$13.2B
$7K ﹤0.01%
300
– –
SLAB icon
579
Silicon Laboratories
SLAB
$7.16B
$7K ﹤0.01%
42
– –
SPSM icon
580
State Street SPDR Portfolio S&P 600 Small Cap ETF
SPSM
$16.9B
$7K ﹤0.01%
+193
New +$7.17K
TAK icon
581
Takeda Pharmaceutical
TAK
$55.1B
$7K ﹤0.01%
460
– –
TTC icon
582
Toro Company
TTC
$8.93B
$7K ﹤0.01%
64
+2
+3% +$205
ZBRA icon
583
Zebra Technologies
ZBRA
$12.4B
$7K ﹤0.01%
22
+1
+5% +$281
ITCI
584
DELISTED
Intra-Cellular Therapies Inc.
ITCI
$7K ﹤0.01%
108
– –
HCP
585
DELISTED
HashiCorp, Inc. Class A Common Stock
HCP
$7K ﹤0.01%
+250
New +$7.33K
ACHC icon
586
Acadia Healthcare
ACHC
$3.17B
$6K ﹤0.01%
77
– –
ACWX icon
587
iShares MSCI ACWI ex US ETF
ACWX
$11.3B
$6K ﹤0.01%
129
– –
ADC icon
588
Agree Realty
ADC
$9.69B
$6K ﹤0.01%
84
– –
AIVI icon
589
WisdomTree International AI Enhanced Value Fund
AIVI
$60M
$6K ﹤0.01%
147
– –
ARES icon
590
Ares Management
ARES
$28.5B
$6K ﹤0.01%
62
-1
-2% -$86
BFAM icon
591
Bright Horizons
BFAM
$3.99B
$6K ﹤0.01%
69
+28
+68% +$2.37K
BIO icon
592
Bio-Rad Laboratories Class A
BIO
$8.42B
$6K ﹤0.01%
17
+4
+31% +$1.63K
BTU icon
593
Peabody Energy
BTU
$2.78B
$6K ﹤0.01%
281
-4
-1% -$89
DOCU
594
DocuSign
DOCU
$9.63B
$6K ﹤0.01%
115
-69
-38% -$3.65K
DVYE icon
595
iShares Emerging Markets Dividend ETF
DVYE
$1.22B
$6K ﹤0.01%
250
– –
EGP icon
596
EastGroup Properties
EGP
$11.5B
$6K ﹤0.01%
33
+1
+3% +$167
EXPO icon
597
Exponent
EXPO
$2.98B
$6K ﹤0.01%
64
– –
FCPT icon
598
Four Corners Property Trust
FCPT
$2.86B
$6K ﹤0.01%
224
– –
GMED icon
599
Globus Medical
GMED
$10.4B
$6K ﹤0.01%
95
+1
+1% +$57
GSK icon
600
GSK
GSK
$103B
$6K ﹤0.01%
160
– –
22 23
24
25 26

Similar funds

SM
Skaana Management Brooklyn, New York $296M AUM 65.1% 1-Year Est. Return
RHP
Royal Harbor Partners Houston, Texas $295M AUM 14.06% 1-Year Est. Return
MSWM
Master's Wealth Management Lancaster, Pennsylvania $295M AUM 15.96% 1-Year Est. Return
RLIM
Red Lighthouse Investment Management New York $296M AUM 22.04% 1-Year Est. Return
JCM
Jacobsen Capital Management Salt Lake City, Utah $296M AUM 24.47% 1-Year Est. Return
CA
Claar Advisors New York $295M AUM 12.26% 1-Year Est. Return
NRC
New Republic Capital Charlotte, North Carolina $297M AUM 24.5% 1-Year Est. Return
MFC
Morris Financial Concepts Mount Pleasant, South Carolina $295M AUM 17.25% 1-Year Est. Return

Front Row Advisors's Q2 2023 Portfolio in Review

As of Q2 2023, Front Row Advisors held 984 positions worth $225M, up 7.8% from $208M the previous quarter. Its ten largest holdings account for 38% of the portfolio.

Front Row Advisors's Q2 2023 filing shows 21 new, 118 increased, 237 reduced and 53 closed positions. Its largest new stake was JPMorgan Nasdaq Equity Premium Income ETF: 635 shares worth $31K. The largest sale was Medtronic, an estimated $817K.

By sector, the portfolio is most concentrated in Technology at 42% of assets, up from 38% a quarter earlier, followed by Healthcare and Financials.

  • Front Row Advisors's largest Q2 2023 buy was JPMorgan Nasdaq Equity Premium Income ETF: 635 shares worth $31K.
  • Front Row Advisors added most to Invesco QQQ Trust in Q2 2023, an estimated $99K increase.
  • Front Row Advisors's biggest Q2 2023 reduction was Medtronic, cutting an estimated $817K.
  • Front Row Advisors fully exited ProShares UltraShort S&P500 in Q2 2023, selling an estimated $97K.
  • Front Row Advisors's ten largest holdings make up 38% of its $225M portfolio in Q2 2023.
  • Front Row Advisors opened 21 new positions and closed 53 in Q2 2023.
  • Front Row Advisors's portfolio value rose 7.8% quarter-over-quarter to $225M.

Based on Front Row Advisors's 13F filing for Q2 2023, filed 15 Aug 2023.